Pfizer (PFE)

R&D Expense Growth

6.93%

Quarterly · Period ending:

PFE logo

PFE R&D Expense Growth

Latest reported6.93%
PFE Quarterly R&D Growth (QoQ) (0.00% → 6.93%)
High-resolution chart · PNG

PFE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
8.5603%
-18.6065%
23.2195%
-5.6169%
52.5281%
-6.3158%
9.5101%
4.048%
1.8321%
-6.1605%
26.9091%
-4.1812%
13.6634%
-12.4783%
20.9644%
3.4707%
-15.4128%
0%
-100%
0%
0%
0%
-100%
1.4768%
11.007%
0%
-100%
16.8067%
1.1331%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.